Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy

Journal of Affective Disorders

Volumn 120, Issue 1-3, 2010, Pages 40-47

  Kraus, John E ^a   Horrigan, Joseph P ^a   Carpenter, David J ^a   Fong, Regan ^a   Barrett, Pamela S ^a   Davies, John T ^b  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antidepressants; Major depressive disorder; Paroxetine; Suicidality

Indexed keywords

PAROXETINE; PLACEBO;

ABRASION; AGITATION; AKATHISIA; ALCOHOL INTOLERANCE; ANXIETY; ANXIETY DISORDER; ARTICLE; BACKACHE; CHILL; CLINICAL TRIAL; COMMON COLD; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG OVERDOSE; EAR INFECTION; EPIGASTRIC PAIN; EPISTAXIS; FATIGUE; HAMILTON SCALE; HAND INJURY; HOPELESSNESS; HUMAN; INDIGESTION; INSOMNIA; MAJOR DEPRESSION; MANIA; MENTAL STRESS; MIXED MANIA AND DEPRESSION; MYDRIASIS; OBSESSIVE COMPULSIVE DISORDER; PAIN; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHOULDER DISLOCATION; SIDE EFFECT; SINUS CONGESTION; SLEEP; SOCIAL PHOBIA; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; TONGUE DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANXIETY DISORDERS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PAROXETINE; QUESTIONNAIRES; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 71649102804     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.04.004     Document Type: Article

References (33)

1. Akiskal H.S., and Benazzi F. Family history validation of the bipolar nature of depressive mixed states. J. Affect. Disord. 73 (2003) 113-122
2. Balázs J., Benazzi F., Rihmer Z., Rihmer A., Akiskal K.K., and Akiskal H.S. The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord. 91 (2006) 133-138
3. Beasley Jr. C.M., Dornseif B.E., Bosomworth J.C., Sayler M.E., Rampey Jr. A.H., Heiligenstein J.H., Thompson V.L., Murphy D.J., and Masica D.N. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 303 (1991) 685-692
4. Bostwick J.M. Do SSRIs cause suicide in children? The evidence is underwhelming. J. Clin. Psychol. 62 (2006) 235-241
5. Busch K.A., Fawcett J., and Jacobs D.G. Clinical correlates of inpatient suicide. J. Clin. Psychiatry 64 (2003) 14-19
6. den Boer J.A. Social anxiety disorder/social phobia: epidemiology, diagnosis, neurobiology, and treatment. Compr. Psychiatry 41 (2000) 405-415
7. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Psychopharmacological Drugs Advisory Committee. September 20, 1991. Available at: www.fda.gov/ohrms/dockets/ac/prozac/2443T1.PDF (accessed September 10, 2008).
8. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Psychopharmacological Drugs Advisory Committee. December 13, 2006. Available at: www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf (accessed September 10, 2008).
9. Detre T.P., and Jarecki H.G. Modern Psychiatric Treatment (1971), Lippincott, Philadelphia, PA
10. Donovan S., Kelleher M.J., Lambourn J., and Foster T. The occurrence of suicide following prescription antidepressant drugs. Arch. Suicide Res. 5 (1999) 181-192
11. Donovan S., Clayton A., Beeharry M., Jones S., Kirk C., Waters K., Gardner D., Faulding J., and Madeley R. Deliberate self-harm and antidepressant drugs. Investigation of a possible link. Br. J. Psychiatry 177 (2000) 551-556
12. Earle K.A., Forquer S.L., Volo A.M., and McDonnell P.M. Characteristics of outpatient suicides. Hosp. Community Psychiatr. 45 (1994) 123-126
13. Fong R., Lipschitz A., Carpenter D.J., Wetherhold E.A., Krulewicz S., and Perera P. Suicidality in clinical trials: using multiple search strategies. Washington (DC), Am Acad Child Adolesc Psychiatry (AACAP) 51st Annual Meeting, October 19-24 (abstract number NRP-223) (2004)
14. GSK 2006 Analysis. Available at: www.gsk.com/media/par_current_analysis.htm (accessed September 10, 2008).
15. GSK Clinical Trial Registry available at: http://ctr.gsk.co.uk/welcome.asp (accessed September 10, 2008).
16. Hall R.C., Platt D.E., and Hall R.C. Suicide risk assessment: a review of risk factors for suicide in 100 patients who made severe suicide attempts. Evaluation of suicide risk in a time of managed care. Psychosomatics 40 (1999) 18-27
17. Hamilton M.S., and Opler L.A. Akathisia, suicidality, and fluoxetine. J. Clin. Psychiatry 53 (1992) 401-406
18. Hammad T.A., Laughren T., and Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch. Gen. Psychiatry 63 (2006) 332-339
19. Heikkinen M.E., Henriksson M.M., Isometsa E.T., Marttunen M.J., Aro H.M., and Lonnqvist J.K. Recent life events and suicide in personality disorders. J. Nerv. Ment. Dis. 185 (1997) 373-381
20. Horesh N., Sever J., and Apter A. A comparison of life events between suicidal adolescents with major depression and borderline personality disorder. Compr. Psychiatry 44 (2003) 277-283
21. Jick H., Kaye J.A., and Jick S.S. Antidepressants and the risk of suicidal behaviors. JAMA 292 (2004) 338-343
22. Kelly T.M., Soloff P.H., Lynch K.G., Haas G.L., and Mann J.J. Recent life events, social adjustment, and suicide attempts in patients with major depression and borderline personality disorder. J. Pers. Disord. 14 (2000) 316-326
23. Kessler R.C., Berglund P., Borges G., Nock M., and Wang P.S. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 293 (2005) 2487-2495
24. Mann J.J., Waternaux C., Haas G.L., and Malone K.M. Toward a clinical model of suicidal behavior in psychiatric patients. Am. J. Psychiatry 156 (1999) 181-189
25. Montgomery S.A., Montgomery D., Baldwin D., and Green M. Intermittent 3-day depressions and suicidal behaviour. Neuropsychobiology 22 (1989) 128-134
26. Oquendo M.A., Galfalvy H., Russo S., Ellis S.P., Grunebaum M.F., Burke A., and Mann J.J. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am. J. Psychiatry 161 (2004) 1433-1441
27. Perlis R.H., Beasley Jr. C.M., Wines Jr. J.D., Tamura R.N., Cusin C., Shear D., Amsterdam J., Quitkin F., Strong R.E., Rosenbaum J.F., and Fava M. Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes. Psychother. Psychosom. 76 (2007) 40-46
28. Pezawas L., Angst J., Gamma A., Ajdacic V., Eich D., and Rossler W. Recurrent brief depression-past and future. Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 (2003) 75-83
29. Rihmer Z., and Akiskal H. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J. Affect. Disord. 94 (2006) 3-13
30. Simon G.E., Savarino J., Operskalski B., and Wang P.S. Suicide risk during antidepressant treatment. Am. J. Psychiatry 163 (2006) 41-47
31. Statham D.J., Heath A.C., Madden P.A., Bucholz K.K., Bierut L., Dinwiddie S.H., Slutske W.S., Dunne M.P., and Martin N.G. Suicidal behaviour: an epidemiological and genetic study. Psychol. Med. 28 (1998) 839-855
32. Teicher M.H., Glod C., and Cole J.O. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am. J. Psychiatry 147 (1990) 207-210
33. Teicher M.H., Glod C.A., and Cole J.O. Antidepressant drugs and the emergence of suicidal tendencies. Drug Safety 8 (1993) 186-212